Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine

Scandinavian Journal of Rheumatology

Volumn 30, Issue 3, 2001, Pages 135-142

  Larsen, Arvi ^a   Kvien, Tore K ^b   Schattenkirchner, Manfred ^c   Rau, Rolf ^d   Scott, David L ^e   Smolen, Josef S ^f   Rozman, Blaz ^g   Westhovens, R ^h   Tikly, Mohammed ⁱ   Oed, Christine ^j   Rosenburg, Ronald ^j  

^a NORWEGIAN KNOWLEDGE CENTRE FOR THE HEALTH SERVICES   (Norway)

^b DIAKONHJEMMET HOSPITAL   (Norway)

^c UNIVERSITY OF MUNICH   (Germany)

^d Evangelisches Fach krankenhaus Ratingen   (Germany)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^h UNIVERSITY OF LEUVEN   (Belgium)

ⁱ UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^j SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

more..

Author keywords

DMARDs; Larsen scores; Leflunomide; Radiographic disease progression; Randomized controlled trials; Rheumatoid arthritis; Sulfasalazine

Indexed keywords

LEFLUNOMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; ARTICLE; BONE RADIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; JOINT DESTRUCTION; LARSEN SCORE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; SULFASALAZINE; TREATMENT OUTCOME;

EID: 17744387698     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/030097401300162897     Document Type: Article

References (55)

1. Eberhardt KB, Rydgren LC, Pettersson H, Wollheim FA. Early rheumatoid arthritis-onset, course, and outcome over 2 years. Rheumatol Int 1990;10:135-42.
2. van der Heijde DMFM, van Riel PLCM, van Leeuwen MA, Van't Hof MA, van Rijswijk MH, van de Putte LBA. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 1992;31:519-25.
3. Scott DL, Grindulis KA, Struthers GR, Coulton BL, Popert AJ, Bacon PA. Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis 1984;43:8-17.
4. Sany J, Kaliski S, Couret M, Cuchacovich M, Daures J. Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis. J Rheumatol 1990;17:1636-41.
5. Mulherin D, Fitzgerald O, Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 1996;35:1263-8.
6. Kirwan JR. Conceptual issues in scoring radiographic progression in rheumatoid arthritis. J Rheumatol 1999;26:720-5.
7. Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of cyclophosphamide in rheumatoid arthritis. N Engl J Med 1970;283:883-9.
8. Cooperating Clinics Committee of the American Rheumatism Association. A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 1973;16:353-8.
9. Larsen A, Horton J, Howland C. The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis. Clin Rheumatol 1984;3 Suppl 1:97-104.
10. Buckland-Wright JC. Advances in the radiological assessment of rheumatoid arthritis. Br J Rheumatol 1983;22 Suppl:34-43.
11. Luukkainen R. Chrysotherapy in rheumatoid arthritis with particular emphasis on the effect of Chrysotherapy on radiological changes and on the optimal time of initiation of therapy. Scand J Rheumatol 1980;34 Suppl:1-56.
12. Gibson T, Huskisson EC, Wojtulewski JA, Scott PJ, Balme HW, Burry HC, et al. Evidence that D-penicillamine alters the course of rheumatoid arthritis. Rheumatol Rehab 1976;15:211-5.
13. Pullar T, Hunter JA, Capell HA. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis 1987;46:398-402.
14. van der Heijde DMFM, van Riel PLCM, Nuver-Zwart IH, van de Putte LBA, Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up {abstract}. Lancet 1990;335:539.
15. Borg G, Allander E, Lund B, Berg E, Brodin U, Pettersson H, et al. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double-blind, placebo-controlled study. J Rheumatol 1988;15:1747-54.
16. Rau R, Herborn G, Karger T, Menninger H, Elhardt D, Schmitt J. A double-blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis. J Rheumatol 1991;18:328-33.
17. Lopez-Mendez A, Daniel WW, Reading JC, Ward JR, Alarcón GS. Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two. Arthritis Rheum 1993;36:1364-9.
18. Weinblatt ME, Polisson R, Blotner SD, Sosman JL, Aliabadi P, Baker N, et al. The effects of drug therapy on radiographic progression of rheumatoid arthritis. Arthritis Rheum 1993;36:613-9.
19. Forre Ø, Norwegian Arthritis Study Group. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporin, Results of a 48-week multicenter study comparing low-dose cyclosporin with placebo. Arthritis Rheum 1994;37:1506-12.
20. Pasero G, Priolo F, Marubini E, Fantini F, Ferraccioli G, Magaro M, et al. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum 1996;39:1006-15.
21. Boers M, Verhoeven AC, Markusse HM, van de Laar MAF, Westhovens R, van Denderen JC, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-18.
22. Kremer JM. Methotrexate and radiographic disease progression in patients with rheumatoid arthritis. J Rheumatol 1999;26:241-3.
23. Alarcón GS, López-Méndez A, Walter J, Boerbooms AMT, Russell AS, Furst DE, et al. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease-modifying antirheumatic drug-treated rheumatoid arthritis patients: a meta-analysis. J Rheumatol 1992;19:1873.
24. Rau R, Herborn G, Menninger H, Sangha O. Progression in early erosive rheumatoid arthritis: 12-month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate. Br J Rheumatol 1998;37:1220-6.
25. Maravic M, Bologna C, Daures J-P, Jorgensen C, Combe B, Sany J. Radiologic progression in early rheumatoid arthritis treated with methotrexate. J Rheumatol 1999;26:262-7.
26. Kremer JM, Lee JK. A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Arthritis Rheum 1988;31:577-84.
27. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 1995;333:142-6.
28. Bartlett RR, Anagnostopulos H, Zielinski T, Mattar T, Schleyerbach R. Effects of leflunomide on immune responses and models of inflammation. Springer Semin Immunopathol 1993;14:381-94.
29. Rückemann K, Fairbanks L, Carrey E, Hawrylowiez C, Richards D, Kirschbaum B, et al. Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 1998;273:21682-91.
30. Bartlett RR, Popovic S, Raiss RX. Development of autoimmunity in MRL/lpr mice and the effects of drugs on this murine disease. Scand J Rheumatol 1988;75:290-9.
31. Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Loew-Friedrich I, et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. Lancet 1999;353:259-66.
32. Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, et al. Treatment of active rheumatoid arthritis with leflunomide compared to placebo and methotrexate. Arch Intern Med 1999;159:2542-50.
33. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
34. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977;18:481-91.
35. Larsen A. Radiographic evaluation of rheumatoid arthritis in therapeutic trials. In: Paulus HE, Ehrlich GE, Lindenlaub E, eds. Controversies in the clinical evaluation of analgesi-anti-Inflammatory - Antirheumatic drugs. New York: F.K. Schattauer Verlag; 1980:323-38.
36. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
37. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
38. Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis. Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 2000;43:495-505.
39. Paulus HE. Heterogeneity in rheumatoid arthritis radiographic trials. Issues to consider in a metaanalysis. J Rheumatol 2000;27:249-50.
40. Sharp JT. An overview of radiographic analysis of joint damage in rheumatoid arthritis and its use in metaanalysis. J Rheumatol 2000;27:254-60.
41. Box SA, Pullar T. Sulphasalazine in the treatment of rheumatoid arthritis. Br J Rheumatol 1997;36:382-6.
42. Möttönen T, Hannonen P, Leirisalo-Repo M, Nissila M, Kautiainen H, Korpela M, et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 1999;353:1568-73.
43. Möttönen TT. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988;47:648-53.
44. Larsen A, Thoen J. Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year. Scand J Rheumatol 1987;16:395-401.
45. Wolfe F, Sharp JT. Radiographic outcome of recent-onset rheumatoid arthritis. A 19-year study of radiographic progression. Arthritis Rheum 1998;41:1571-82.
46. Larsen A. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis. Scand J Rheumatol 1988;17:123-9.
47. Dawes PT, Fowler PD, Clarke S, Fisher J, Lawton A, Shadforth MF. Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol 1986;25:44-9.
48. Coste J, Spira A, Clerc D, Paolaggi JB. Prediction of articular destruction in rheumatoid arthritis: disease activity markers revisited. J Rheumatol 1997;24:28-34.
49. Graudal N, Tarp U, Jurik AG, Galloe AM, Garred P, Milman N, et al. Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: long-term course and association to radiographic progression. J Rheumatol 2000;27:47-57.
50. Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985;28:1326-35.
51. Kuper IH, van Leeuwen MA, van Riel PLCM, Sluiter WJ, Houtman NM, Cats HA, et al. Influence of a ceiling effect on the assessment of radiographic progression in rheumatoid arthritis during the first 6 years of disease. J Rheumatol 1999;26:268-76.
52. Wassenberg S, Rau R. Problems in evaluating radiographic findings in rheumatoid arthritis using different methods of radiographic scoring: examples of difficult cases and a study design to develop an improved scoring method. J Rheumatol 1995;22:1990-7.
53. van der Heijde D, Boonen A, Boers M, Kostense P, van der LS. Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials. Rheumatology 1999;38:1213-20.
54. Menninger H, Meixner C, Söndgen W. Progression and repair in radiographs of hands and forefeet in early rheumatoid arthritis. J Rheumatol 1995;22:1048-54.
55. Rau R, Herborn G. A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 1995;22:1976-82.